Differential	O
contribution	O
of	O
herpes	B-protein
simplex	I-protein
virus	I-protein
type	I-protein
1	I-protein
gene	I-protein
products	I-protein
and	O
cellular	B-protein
factors	I-protein
to	O
the	O
activation	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
provirus	O
.	O

We	O
have	O
previously	O
reported	O
that	O
infection	O
with	O
herpes	O
simplex	O
virus	O
type	O
1	O
(	O
HSV-1	O
)	O
activates	O
expression	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
provirus	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

Activation	O
of	O
the	O
HIV-1	O
provirus	O
correlated	O
with	O
the	O
activation	O
of	O
binding	O
of	O
55-	B-protein
and	I-protein
85-kDa	I-protein
proteins	I-protein
to	O
the	O
kappa	B-DNA
B	I-DNA
enhancer	I-DNA
and	O
binding	O
of	O
the	O
50-kDa	B-protein
HLP-1	I-protein
protein	I-protein
to	O
the	O
LBP-1	B-DNA
sequences	I-DNA
of	O
the	O
HIV-1	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
.	O

Further	O
examination	O
of	O
this	O
system	O
has	O
shown	O
that	O
the	O
inhibition	O
of	O
HSV-1	O
replication	O
by	O
the	O
antiviral	O
drug	O
acyclovir	O
does	O
not	O
inhibit	O
HSV-1-mediated	O
induction	O
of	O
HIV-1	O
provirus	O
.	O

Surprisingly	O
,	O
the	O
NF-kappa	B-protein
B	I-protein
and	O
HLP-1	O
binding	O
activities	O
were	O
substantially	O
inhibited	O
in	O
acyclovir-treated	B-cell_line
cells	I-cell_line
.	O

In	O
the	O
transient-transfection	O
assay	O
,	O
ICP0	B-protein
,	O
but	O
not	O
ICP4	B-protein
,	O
activated	O
the	O
HIV-1	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
promoter	I-DNA
region	I-DNA
and	O
the	O
effect	O
of	O
ICP0	B-protein
was	O
greatly	O
enhanced	O
in	O
the	O
presence	O
of	O
the	O
NF-kappa	B-protein
B	I-protein
binding	I-protein
proteins	I-protein
,	O
suggesting	O
that	O
induction	O
of	O
the	O
HIV-1	O
provirus	O
involves	O
cooperation	O
between	O
the	O
HSV-1-activated	B-protein
cellular	I-protein
factor	I-protein
,	O
NF-kappa	B-protein
B	I-protein
,	O
and	O
the	O
virus-encoded	B-protein
transactivator	I-protein
,	O
ICP0	B-protein
.	O

JouRNAL	NULL
or	NULL
ViroLOGY	NULL
,	NULL
July	NULL
1993	NULL
,	NULL
p.	NULL
4427-4431	NULL
0022-538	NULL
X/93/074427-05	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1993	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

67	NULL
,	NULL
No	NULL
.	NULL

7	NULL
Differential	NULL
Contribution	NULL
of	NULL
Herpes	NULL
Simplex	NULL
Virus	NULL
Type	NULL
1	NULL
Gene	NULL
Products	NULL
and	NULL
Cellular	NULL
Factors	NULL
to	NULL
the	NULL
Activation	NULL
of	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Type	NULL
1	NULL
Provirus	NULL
JAROMIR	NULL
VLACH	NULL
'	NULL
anp	NULL
PAULA	NULL
M.	NULL
PITHA*	NULL
``	NULL
*	NULL
Oncology	NULL
Center'*	NULL
and	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
and	NULL
Genetics	NULL
,	NULL
``	NULL
The	NULL
Johns	NULL
Hopkins	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Baltimore	NULL
,	NULL
Maryland	NULL
21231	NULL
Received	NULL
31	NULL
December	NULL
1992/Accepted	NULL
5	NULL
April	NULL
1993	NULL
We	NULL
have	NULL
previously	NULL
reported	NULL
that	NULL
infection	NULL
with	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HSV-1	NULL
)	NULL
activates	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
provirus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
HIV-1	NULL
provirus	NULL
correlated	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
binding	NULL
of	NULL
55-	NULL
and	NULL
85-kDa	NULL
proteins	NULL
to	NULL
the	NULL
«	NULL
B	NULL
enhancer	NULL
and	NULL
binding	NULL
of	NULL
the	NULL
50-kDa	NULL
HLP-1	NULL
protein	NULL
to	NULL
the	NULL
LBP-1	NULL
sequences	NULL
of	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Further	NULL
examination	NULL
of	NULL
this	NULL
system	NULL
has	NULL
shown	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
HSV-1	NULL
replication	NULL
by	NULL
the	NULL
antiviral	NULL
drug	NULL
acyclovir	NULL
does	NULL
not	NULL
inhibit	NULL
HSV-1-mediated	NULL
induction	NULL
of	NULL
HIV-1	NULL
provirus	NULL
.	NULL

Surprisingly	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
HLP-1	NULL
binding	NULL
activities	NULL
were	NULL
substantially	NULL
inhibited	NULL
in	NULL
acyclovir-treated	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
transient-transfection	NULL
assay	NULL
,	NULL
ICPO	NULL
,	NULL
but	NULL
not	NULL
ICP4	NULL
,	NULL
activated	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
promoter	NULL
region	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
ICPO	NULL
was	NULL
greatly	NULL
enhanced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
proteins	NULL
,	NULL
suggesting	NULL
that	NULL
induction	NULL
of	NULL
the	NULL
HIV-1	NULL
provirus	NULL
involves	NULL
cooperation	NULL
between	NULL
the	NULL
HSV-1l-activated	NULL
cellular	NULL
factor	NULL
,	NULL
NF-B	NULL
,	NULL
and	NULL
the	NULL
virus-encoded	NULL
transactivator	NULL
,	NULL
ICPO	NULL
.	NULL

Expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
in	NULL
chronically	NULL
infected	NULL
cells	NULL
can	NULL
be	NULL
stimulated	NULL
by	NULL
several	NULL
agents	NULL
,	NULL
including	NULL
cytokines	NULL
,	NULL
phorbol	NULL
esters	NULL
,	NULL
mito-gens	NULL
,	NULL
and	NULL
infection	NULL
with	NULL
heterologous	NULL
viruses	NULL
(	NULL
5	NULL
,	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
herpesvirus	NULL
family	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
stimulate	NULL
transcription	NULL
driven	NULL
by	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
,	NULL
and	NULL
we	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
infection	NULL
with	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HSV-1	NULL
)	NULL
induces	NULL
HIV-1	NULL
expression	NULL
in	NULL
the	NULL
chronically	NULL
infected	NULL
T-lymphocytic	NULL
cell	NULL
line	NULL
ACH-2	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
provirus	NULL
transcription	NULL
by	NULL
HSV-1	NULL
correlates	NULL
with	NULL
binding	NULL
of	NULL
the	NULL
55-	NULL
and	NULL
85-kDa	NULL
proteins	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
and	NULL
with	NULL
binding	NULL
of	NULL
the	NULL
50-kDa	NULL
protein	NULL
(	NULL
HLP-1	NULL
)	NULL
to	NULL
the	NULL
LBP-1	NULL
site	NULL
in	NULL
the	NULL
leader	NULL
sequence	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
20	NULL
)	NULL
.	NULL

In	NULL
transient-expression	NULL
assays	NULL
using	NULL
the	NULL
HIV-1	NULL
LTR	NULL
CAT	NULL
plasmids	NULL
,	NULL
the	NULL
herpesvirus-en-coded	NULL
transactivators	NULL
ICPO	NULL
and	NULL
ICP4	NULL
were	NULL
also	NULL
shown	NULL
to	NULL
stimulate	NULL
the	NULL
HIV-1	NULL
LTR-directed	NULL
transcription	NULL
(	NULL
11-14	NULL
,	NULL
16	NULL
,	NULL
22	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
activation	NULL
by	NULL
the	NULL
immediate-early	NULL
proteins	NULL
(	NULL
IE	NULL
)	NULL
,	NULL
ICPO	NULL
and	NULL
ICP4	NULL
,	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
associated	NULL
with	NULL
binding	NULL
to	NULL
any	NULL
specific	NULL
DNA	NULL
sequence	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
transient-expression	NULL
assay	NULL
,	NULL
the	NULL
overexpression	NULL
of	NULL
ICPO	NULL
or	NULL
ICP4	NULL
is	NULL
able	NULL
neither	NULL
to	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
integrated	NULL
HIV-1	NULL
provirus	NULL
nor	NULL
to	NULL
induce	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
HLP-1	NULL
proteins	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Replication	NULL
of	NULL
HSV-1	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
the	NULL
nucleoside	NULL
analog	NULL
acyclovir	NULL
(	NULL
ACV	NULL
)	NULL
,	NULL
which	NULL
is	NULL
effectively	NULL
incorporated	NULL
into	NULL
the	NULL
newly	NULL
formed	NULL
viral	NULL
DNA	NULL
with	NULL
consequent	NULL
premature	NULL
termination	NULL
of	NULL
viral	NULL
DNA	NULL
syn-thesis	NULL
.	NULL

It	NULL
was	NULL
shown	NULL
that	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ACV	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
IE	NULL
and	NULL
the	NULL
early	NULL
HSV-1	NULL
genes	NULL
is	NULL
not	NULL
altered	NULL
but	NULL
expression	NULL
of	NULL
the	NULL
late	NULL
genes	NULL
is	NULL
inhibited	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
examined	NULL
whether	NULL
the	NULL
treatment	NULL
of	NULL
HSV-1l-infected	NULL
cells	NULL
with	NULL
ACV	NULL
inhibits	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
provirus	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
the	NULL
HIV-1	NULL
provirus	NULL
was	NULL
studied	NULL
in	NULL
a	NULL
T-lymphocytic	NULL
cell	NULL
line	NULL
,	NULL
ACH-2	NULL
(	NULL
4	NULL
)	NULL
,	NULL
containing	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
HIV-1	NULL
provirus	NULL
.	NULL

Activation	NULL
of	NULL
HIV-1	NULL
expression	NULL
in	NULL
these	NULL
cells	NULL
by	NULL
HSV-1	NULL
infection	NULL
was	NULL
described	NULL
recently	NULL
(	NULL
20	NULL
)	NULL
.	NULL

*	NULL
Corresponding	NULL
author	NULL
.	NULL

4427	NULL
The	NULL
ACH-2	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
HSV-1	NULL
at	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
(	NULL
MOT	NULL
)	NULL
of	NULL
1	NULL
to	NULL
3	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
5	NULL
or	NULL
30	NULL
uM	NULL
)	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
ACV	NULL
,	NULL
and	NULL
the	NULL
HIV-1-specific	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
(	NULL
immunoblot	NULL
)	NULL
analysis	NULL
at	NULL
16	NULL
and	NULL
40	NULL
h	NULL
postinfection	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
HIV-1-specific	NULL
proteins	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
ACV	NULL
were	NULL
about	NULL
the	NULL
same	NULL
.	NULL

Treatment	NULL
of	NULL
the	NULL
ACH-2	NULL
cells	NULL
with	NULL
ACV	NULL
alone	NULL
did	NULL
not	NULL
alter	NULL
HIV-1	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
ACV	NULL
treatment	NULL
on	NULL
HIV-1	NULL
transcription	NULL
in	NULL
ACH-2	NULL
cells	NULL
infected	NULL
with	NULL
HSV-1	NULL
.	NULL

Cells	NULL
were	NULL
infected	NULL
with	NULL
HSV-1	NULL
at	NULL
an	NULL
MOI	NULL
of	NULL
3	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
ACV	NULL
(	NULL
5	NULL
and	NULL
30	NULL
wM	NULL
)	NULL
,	NULL
and	NULL
the	NULL
levels	NULL
of	NULL
HIV-1	NULL
transcripts	NULL
at	NULL
4	NULL
and	NULL
8	NULL
h	NULL
postinfection	NULL
were	NULL
determined	NULL
by	NULL
S1	NULL
mapping	NULL
using	NULL
the	NULL
HIV-1	NULL
antisense	NULL
riboprobe	NULL
spanning	NULL
the	NULL
first	NULL
80	NULL
bases	NULL
of	NULL
all	NULL
HIV-1	NULL
transcripts	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

While	NULL
no	NULL
stimulation	NULL
of	NULL
the	NULL
HIV-1	NULL
transcription	NULL
could	NULL
be	NULL
detected	NULL
4	NULL
h	NULL
after	NULL
HSV-1	NULL
infection	NULL
,	NULL
at	NULL
8	NULL
h	NULL
postinfection	NULL
the	NULL
levels	NULL
of	NULL
HIV-1	NULL
transcripts	NULL
were	NULL
increased	NULL
in	NULL
HSV-l-infected	NULL
cells	NULL
and	NULL
the	NULL
relative	NULL
levels	NULL
of	NULL
HIV-1	NULL
transcripts	NULL
present	NULL
in	NULL
ACV	NULL
-treated	NULL
cells	NULL
were	NULL
higher	NULL
than	NULL
in	NULL
the	NULL
controls	NULL
.	NULL

The	NULL
increase	NULL
was	NULL
proportional	NULL
to	NULL
the	NULL
concentration	NULL
of	NULL
ACV	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
ACH-2	NULL
cells	NULL
with	NULL
ACV	NULL
alone	NULL
did	NULL
not	NULL
result	NULL
in	NULL
any	NULL
stimulation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

The	NULL
ACV	NULL
treatment	NULL
also	NULL
had	NULL
a	NULL
marked	NULL
effect	NULL
on	NULL
HSV-1-stimulated	NULL
production	NULL
of	NULL
HIV-1	NULL
.	NULL

In	NULL
HSV-1-infected	NULL
ACH-2	NULL
cells	NULL
,	NULL
virus	NULL
production	NULL
was	NULL
markedly	NULL
increased	NULL
at	NULL
24	NULL
h	NULL
postinfection	NULL
but	NULL
then	NULL
declined	NULL
due	NULL
to	NULL
the	NULL
cytopathic	NULL
effect	NULL
of	NULL
HSV-1	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ACV	NULL
,	NULL
HIV-1	NULL
virions	NULL
were	NULL
effectively	NULL
synthesized	NULL
even	NULL
at	NULL
96	NULL
h	NULL
postinduction	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
ACV-induced	NULL
block	NULL
in	NULL
HSV-1	NULL
replication	NULL
and	NULL
cell	NULL
death	NULL
led	NULL
to	NULL
prolonged	NULL
production	NULL
of	NULL
HIV-1	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
effectiveness	NULL
of	NULL
ACV	NULL
treatment	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
HSV-1	NULL
genes	NULL
in	NULL
T	NULL
lymphocytes	NULL
,	NULL
we	NULL
have	NULL
analyzed	NULL
the	NULL
expression	NULL
of	NULL
three	NULL
HSV-1	NULL
genes	NULL
,	NULL
ICPO	NULL
,	NULL
tk	NULL
,	NULL
and	NULL
VP16	NULL
,	NULL
which	NULL
represent	NULL
the	NULL
three	NULL
defined	NULL
classes	NULL
of	NULL
the	NULL
immediate-early	NULL
,	NULL
early	NULL
,	NULL
and	NULL
late	NULL
HSV-1	NULL
genes	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
ACH-2	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
HSV-1	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
ACV	NULL
,	NULL
and	NULL
at	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
cells	NULL
were	NULL
4428	NULL
NOTES	NULL
ACV	NULL
{	NULL
uM	NULL
)	NULL
0	NULL
0	NULL
5	NULL
30	NULL
0	NULL
0	NULL
5	NULL
30	NULL
HSV	NULL
(	NULL
hr	NULL
)	NULL
16	NULL
16	NULL
16	NULL
40	NULL
40	NULL
40	NULL
200	NULL
97	NULL
68	NULL
p55	NULL
P	NULL
ima	NULL
6	NULL
6	NULL
43	NULL
29	NULL
p24	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
HIV-1	NULL
proteins	NULL
.	NULL

One	NULL
hundred	NULL
micrograms	NULL
of	NULL
protein	NULL
lysates	NULL
was	NULL
loaded	NULL
on	NULL
sodium	NULL
dodecyl	NULL
sulfate-10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
transferred	NULL
on	NULL
nitrocellulose	NULL
membrane	NULL
,	NULL
and	NULL
the	NULL
HIV-l-specific	NULL
proteins	NULL
were	NULL
detected	NULL
with	NULL
the	NULL
antiserum	NULL
from	NULL
an	NULL
AIDS	NULL
patient	NULL
.	NULL

Cells	NULL
were	NULL
infected	NULL
with	NULL
HSV-1	NULL
at	NULL
an	NULL
MOI	NULL
of	NULL
3	NULL
for	NULL
the	NULL
times	NULL
shown	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
various	NULL
concentrations	NULL
of	NULL
ACV	NULL
(	NULL
Burroughs-Wellcome	NULL
,	NULL
Research	NULL
Triangle	NULL
Park	NULL
,	NULL
N.C.	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
for	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
and	NULL
6	NULL
to	NULL
8	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
5	NULL
represent	NULL
lysates	NULL
prepared	NULL
from	NULL
mock-infected	NULL
cells	NULL
.	NULL

Positions	NULL
of	NULL
Gag	NULL
proteins	NULL
p55	NULL
and	NULL
p24	NULL
are	NULL
indicated	NULL
.	NULL

collected	NULL
and	NULL
RNA	NULL
was	NULL
analyzed	NULL
by	NULL
Northern	NULL
(	NULL
RNA	NULL
)	NULL
hy-bridization	NULL
.	NULL

Figure	NULL
3	NULL
shows	NULL
that	NULL
the	NULL
relative	NULL
levels	NULL
of	NULL
ICPO	NULL
mRNA	NULL
are	NULL
only	NULL
slightly	NULL
lower	NULL
in	NULL
ACV	NULL
-treated	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
levels	NULL
of	NULL
tk	NULL
transcripts	NULL
were	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
ACV	NULL
,	NULL
implying	NULL
that	NULL
ACV	NULL
does	NULL
not	NULL
inhibit	NULL
transcription	NULL
of	NULL
the	NULL
immediate-early	NULL
and	NULL
early	NULL
HSV-1	NULL
genes	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
ACV	NULL
had	NULL
a	NULL
profound	NULL
effect	NULL
on	NULL
transcription	NULL
of	NULL
the	NULL
late	NULL
genes	NULL
,	NULL
and	NULL
even	NULL
5	NULL
wM	NULL
ACV	NULL
significantly	NULL
reduced	NULL
levels	NULL
of	NULL
VP16	NULL
mRNA	NULL
.	NULL

The	NULL
observed	NULL
variation	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
ICPO	NULL
and	NULL
a	NULL
decrease	NULL
in	NULL
VP16	NULL
levels	NULL
are	NULL
not	NULL
due	NULL
to	NULL
the	NULL
difference	NULL
in	NULL
RNA	NULL
loading	NULL
,	NULL
since	NULL
the	NULL
ethidium	NULL
bromide	NULL
staining	NULL
shows	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
RNA	NULL
in	NULL
all	NULL
samples	NULL
.	NULL

The	NULL
observed	NULL
inhibition	NULL
of	NULL
ICPO	NULL
mRNA	NULL
at	NULL
7	NULL
h	NULL
postinfection	NULL
is	NULL
probably	NULL
a	NULL
consequence	NULL
of	NULL
lower	NULL
levels	NULL
of	NULL
VP16	NULL
that	NULL
is	NULL
an	NULL
effective	NULL
transactivator	NULL
of	NULL
ICPO	NULL
gene	NULL
expression	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
latent	NULL
HIV-1	NULL
provirus	NULL
by	NULL
HSV-1	NULL
does	NULL
not	NULL
require	NULL
viral	NULL
replication	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
late	NULL
viral	NULL
genes	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
HSV-l-mediated	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
provirus	NULL
correlated	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
kB	NULL
enhancer	NULL
and	NULL
the	NULL
leader	NULL
region	NULL
of	NULL
HIV-1	NULL
LTR	NULL
(	NULL
20	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
HSV-1L-mediated	NULL
induction	NULL
of	NULL
the	NULL
NF-kB	NULL
and	NULL
HLP-1	NULL
proteins	NULL
is	NULL
altered	NULL
in	NULL
ACV	NULL
-treated	NULL
cells	NULL
,	NULL
we	NULL
used	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
to	NULL
analyze	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
ACV-treated	NULL
and	NULL
non-ACV	NULL
-treated	NULL
,	NULL
HSV-l-infected	NULL
ACH-2	NULL
cells	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
LBP-1	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
ACV	NULL
significantly	NULL
inhibits	NULL
the	NULL
HSV-1-mediated	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
HLP-1	NULL
proteins	NULL
.	NULL

However	NULL
,	NULL
even	NULL
when	NULL
high	NULL
levels	NULL
of	NULL
ACV	NULL
were	NULL
J.	NULL
Viror	NULL
.	NULL

ACV	NULL
(	NULL
pM	NULL
)	NULL
-o	NULL
-	NULL
§	NULL
30	NULL
-	NULL
5	NULL
HSV	NULL
(	NULL
hr	NULL
)	NULL
-	NULL
0	NULL
404	NULL
«	NULL
<	NULL
G	NULL
:	NULL
30	NULL
30	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
%	NULL
/	NULL
>	NULL
1	NULL
.	NULL

HindIII	NULL
I	NULL
I	NULL
I	NULL
I	NULL
«	NULL
<	NULL
1	NULL
16	NULL
97	NULL
TZ	NULL
protected	NULL
probe	NULL
control	NULL
sense	NULL
RNA	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Analysis	NULL
of	NULL
HIV-1	NULL
RNA	NULL
levels	NULL
in	NULL
HSV-1-infected	NULL
ACH-2	NULL
cells	NULL
.	NULL

ACH-2	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
HSV-1	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
ACV	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
at	NULL
4	NULL
and	NULL
8	NULL
h	NULL
postinfection	NULL
by	NULL
the	NULL
acid	NULL
phenol	NULL
method	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Two	NULL
micrograms	NULL
of	NULL
the	NULL
total	NULL
RNA	NULL
was	NULL
hybridized	NULL
with	NULL
4	NULL
x	NULL
10°	NULL
cpm	NULL
of	NULL
labeled	NULL
riboprobe	NULL
(	NULL
described	NULL
below	NULL
)	NULL
in	NULL
40	NULL
mM	NULL
PIPES	NULL
[	NULL
piperazine-N	NULL
,	NULL
N'-bis	NULL
(	NULL
2-ethanesulfonic	NULL
acid	NULL
)	NULL
]	NULL
(	NULL
pH	NULL
6.5	NULL
)	NULL
-1	NULL
mM	NULL
EDTA-0.4	NULL
M	NULL
NaCl-80	NULL
%	NULL
formamide	NULL
for	NULL
16	NULL
h	NULL
at	NULL
50°C	NULL
.	NULL

S1	NULL
nuclease	NULL
was	NULL
added	NULL
in	NULL
0.28	NULL
M	NULL
NaCl-50	NULL
mM	NULL
sodium	NULL
acetate	NULL
(	NULL
pH	NULL
4.5	NULL
)	NULL
-4.5	NULL
mM	NULL
ZnSO	NULL
,	NULL
,	NULL
and	NULL
the	NULL
reaction	NULL
proceeded	NULL
for	NULL
40	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

After	NULL
precipitation	NULL
,	NULL
the	NULL
RNA	NULL
was	NULL
electrophoresed	NULL
through	NULL
an	NULL
8	NULL
%	NULL
sequencing	NULL
gel	NULL
.	NULL

The	NULL
antisense	NULL
riboprobe	NULL
is	NULL
shown	NULL
in	NULL
lane	NULL
1	NULL
.	NULL

Plasmid	NULL
p4TAR30	NULL
contains	NULL
sequences	NULL
Rsal	NULL
(	NULL
-4	NULL
)	NULL
to	NULL
HindIII	NULL
(	NULL
+80	NULL
)	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
inserted	NULL
between	NULL
the	NULL
EcoRI	NULL
and	NULL
HindIII	NULL
sites	NULL
of	NULL
pGem4Z	NULL
(	NULL
Promega	NULL
,	NULL
Madi-son	NULL
,	NULL
Wis.	NULL
)	NULL
.	NULL

The	NULL
antisense	NULL
riboprobe	NULL
was	NULL
prepared	NULL
from	NULL
p4TAR30	NULL
linearized	NULL
with	NULL
Pvull	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
*P	NULL
]	NULL
GTP	NULL
(	NULL
New	NULL
England	NULL
Nuclear	NULL
,	NULL
Boston	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

using	NULL
T7	NULL
RNA	NULL
polymerase	NULL
(	NULL
Boehringer	NULL
,	NULL
Indianapolis	NULL
,	NULL
Ind	NULL
.	NULL
)	NULL

(	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
sense	NULL
RNA	NULL
used	NULL
as	NULL
a	NULL
standard	NULL
in	NULL
lane	NULL
10	NULL
was	NULL
prepared	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
of	NULL
p4TAR30	NULL
linearized	NULL
with	NULL
HindIII	NULL
with	NULL
SP6	NULL
RNA	NULL
polymerase	NULL
(	NULL
Boehringer	NULL
)	NULL
.	NULL

This	NULL
RNA	NULL
gives	NULL
a	NULL
protected	NULL
fragment	NULL
larger	NULL
than	NULL
HIV-1	NULL
transcripts	NULL
due	NULL
to	NULL
its	NULL
complementarity	NULL
with	NULL
the	NULL
antisense	NULL
probe	NULL
in	NULL
the	NULL
region	NULL
of	NULL
the	NULL
SP6	NULL
promoter	NULL
.	NULL

Vor	NULL
.	NULL

67	NULL
,	NULL
1993	NULL
ACV	NULL
(	NULL
uM	NULL
)	NULL
0	NULL
5	NULL
30	NULL
HSV	NULL
(	NULL
hr	NULL
)	NULL
0	NULL
403	NULL
5	NULL
7	NULL
4	NULL
3	NULL
5	NULL
7	NULL
54	NULL
B	NULL
50	NULL
7	NULL
#	NULL
*	NULL
ICPO	NULL
tR	NULL
-	NULL
S*	NULL
.	NULL

an	NULL
.	NULL

tk	NULL
44	NULL
w	NULL
VP16	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Kinetics	NULL
of	NULL
mRNA	NULL
levels	NULL
of	NULL
ICPO	NULL
,	NULL
thymidine	NULL
kinase	NULL
(	NULL
tk	NULL
)	NULL
,	NULL
and	NULL
VP16	NULL
during	NULL
infection	NULL
of	NULL
ACH-2	NULL
cells	NULL
with	NULL
HSV-1	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
the	NULL
total	NULL
RNA	NULL
was	NULL
electrophoresed	NULL
through	NULL
1	NULL
%	NULL
agarose	NULL
containing	NULL
formaldehyde	NULL
,	NULL
blotted	NULL
on	NULL
the	NULL
nitrocellulose	NULL
membrane	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
the	NULL
probes	NULL
specific	NULL
for	NULL
the	NULL
respective	NULL
genes	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
ACV	NULL
used	NULL
during	NULL
infection	NULL
is	NULL
shown	NULL
on	NULL
top	NULL
.	NULL

used	NULL
,	NULL
the	NULL
binding	NULL
was	NULL
not	NULL
completely	NULL
abolished	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
activation	NULL
of	NULL
HIV-1	NULL
provirus	NULL
was	NULL
not	NULL
proportionally	NULL
related	NULL
to	NULL
the	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
proteins	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
that	NULL
even	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-specific	NULL
protein	NULL
binding	NULL
are	NULL
sufficient	NULL
to	NULL
activate	NULL
the	NULL
latent	NULL
HIV-1	NULL
provirus	NULL
(	NULL
19	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
HLP-1	NULL
proteins	NULL
present	NULL
in	NULL
ACV	NULL
-treated	NULL
cells	NULL
are	NULL
sufficient	NULL
to	NULL
activate	NULL
the	NULL
HIV-1	NULL
provirus	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
,	NULL
p23tkCAT	NULL
,	NULL
in	NULL
the	NULL
HSV-l-infected	NULL
and	NULL
ACV	NULL
-treated	NULL
A3.01	NULL
cells	NULL
.	NULL

This	NULL
plasmid	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
HLP-1	NULL
binding	NULL
sites	NULL
in	NULL
front	NULL
of	NULL
the	NULL
tk	NULL
promoter	NULL
,	NULL
is	NULL
effectively	NULL
induced	NULL
in	NULL
HSV-l-infected	NULL
A3.01	NULL
cells	NULL
(	NULL
20	NULL
)	NULL
.	NULL

p23tkCAT	NULL
was	NULL
transfected	NULL
into	NULL
ACV	NULL
-treated	NULL
cells	NULL
or	NULL
untreated	NULL
controls	NULL
,	NULL
and	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
either	NULL
treated	NULL
with	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
or	NULL
infected	NULL
with	NULL
HSV-1	NULL
.	NULL

The	NULL
HIV-1	NULL
LTR	NULL
CAT	NULL
plasmid	NULL
was	NULL
transfected	NULL
for	NULL
comparison	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
show	NULL
that	NULL
,	NULL
while	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
these	NULL
plasmids	NULL
was	NULL
only	NULL
marginal	NULL
and	NULL
PMA	NULL
treatment	NULL
increased	NULL
their	NULL
expression	NULL
about	NULL
threefold	NULL
,	NULL
HSV-1	NULL
infection	NULL
increased	NULL
expression	NULL
of	NULL
p23tkCAT	NULL
by	NULL
25-fold	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
HSV-1	NULL
replication	NULL
in	NULL
ACV	NULL
-treated	NULL
cells	NULL
,	NULL
with	NULL
a	NULL
concomitant	NULL
decrease	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
HLP-1	NULL
binding	NULL
,	NULL
did	NULL
not	NULL
abolish	NULL
expression	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
but	NULL
enhanced	NULL
it	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
the	NULL
HIV-1	NULL
LTR	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
.	NULL

Enhancement	NULL
of	NULL
the	NULL
HSV-1-mediated	NULL
expression	NULL
of	NULL
HIV-1	NULL
LTR	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ACV	NULL
indicates	NULL
that	NULL
products	NULL
encoded	NULL
by	NULL
the	NULL
IE	NULL
or	NULL
the	NULL
early	NULL
HSV-1	NULL
genes	NULL
may	NULL
play	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
.	NULL

The	NULL
best	NULL
candidates	NULL
are	NULL
the	NULL
ICPO	NULL
and	NULL
ICP4	NULL
immediate-early	NULL
genes	NULL
.	NULL

Neither	NULL
the	NULL
relative	NULL
levels	NULL
of	NULL
ICPO	NULL
and	NULL
ICP4	NULL
mRNAs	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
nor	NULL
the	NULL
activities	NULL
of	NULL
their	NULL
promoter	NULL
regions	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
are	NULL
significantly	NULL
affected	NULL
by	NULL
ACV	NULL
treatment	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
ICPO	NULL
and/or	NULL
ICP4	NULL
to	NULL
activate	NULL
transcription	NULL
driven	NULL
by	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
a	NULL
transient-expression	NULL
assay	NULL
has	NULL
been	NULL
documented	NULL
previously	NULL
(	NULL
11-14	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
overexpression	NULL
of	NULL
ICPO	NULL
or	NULL
ICP4	NULL
can	NULL
induce	NULL
neither	NULL
the	NULL
HIV-1	NULL
provirus	NULL
nor	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
HLP-1	NULL
binding	NULL
proteins	NULL
in	NULL
ACH-2	NULL
cells	NULL
(	NULL
21	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
ICPO	NULL
can	NULL
activate	NULL
the	NULL
HIV-1	NULL
LTR	NULL
by	NULL
cooperation	NULL
with	NULL
other	NULL
transactivating	NULL
factors	NULL
,	NULL
especially	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
proteins	NULL
,	NULL
we	NULL
have	NULL
transfected	NULL
the	NULL
p23tkCAT	NULL
plasmid	NULL
into	NULL
A3.01	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
and	NULL
examined	NULL
its	NULL
expression	NULL
upon	NULL
transactivation	NULL
with	NULL
dif-	NULL
NOTES	NULL
4429	NULL
ACV	NULL
0	NULL
-	NULL
-	NULL
-	NULL
5	NULL
30	NULL
ACV	NULL
-	NULL
-	NULL
-	NULL
-	NULL
5	NULL
30	NULL
HSV	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
HSV	NULL
_	NULL
-	NULL
+	NULL
+	NULL
4	NULL
+	NULL
ln	NULL
alities	NULL
o	NULL
B2	NULL
.	NULL

#	NULL
1	NULL
2	NULL
3°	NULL
4	NULL
5	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Electrophoretic	NULL
gel-shift	NULL
analysis	NULL
of	NULL
the	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
NF-kB	NULL
(	NULL
A	NULL
)	NULL
and	NULL
LBP-1	NULL
(	NULL
B	NULL
)	NULL
probes	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
freeze-thaw	NULL
method	NULL
(	NULL
19	NULL
)	NULL
from	NULL
uninfected	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
)	NULL
or	NULL
cells	NULL
infected	NULL
with	NULL
HSV-1	NULL
for	NULL
12	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
30	NULL
uM	NULL
ACV	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
5	NULL
)	NULL
.	NULL

Approximately	NULL
3	NULL
ug	NULL
of	NULL
protein	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
labeled	NULL
probe	NULL
in	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
)	NULL
,	NULL
pH	NULL
7.6-5	NULL
mM	NULL
MgC1	NULL
,	NULL
-50	NULL
mM	NULL
KCI-6	NULL
%	NULL
glycerol-2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
22°C	NULL
and	NULL
then	NULL
electrophoresed	NULL
through	NULL
4	NULL
%	NULL
nondenaturing	NULL
acry-lamide	NULL
gel	NULL
.	NULL

The	NULL
NF-KB	NULL
probe	NULL
contains	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
sequence	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
)	NULL
,	NULL
and	NULL
the	NULL
LBP-1	NULL
probe	NULL
contains	NULL
the	NULL
sequences	NULL
from	NULL
the	NULL
leader	NULL
region	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
in	NULL
lanes	NULL
3	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
unlabeled	NULL
probes	NULL
.	NULL

Both	NULL
radioactive	NULL
probes	NULL
were	NULL
prepared	NULL
by	NULL
fill-in	NULL
reaction	NULL
using	NULL
Klenow	NULL
polymerase	NULL
(	NULL
Life	NULL
Technol-ogies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
N.Y.	NULL
)	NULL
.	NULL

ferent	NULL
inducers	NULL
.	NULL

PMA	NULL
treatment	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
,	NULL
which	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
3-fold	NULL
activation	NULL
of	NULL
the	NULL
CAT	NULL
activity	NULL
,	NULL
whereas	NULL
cotransfection	NULL
with	NULL
ICPO	NULL
(	NULL
under	NULL
the	NULL
control	NULL
of	NULL
a	NULL
cytomegalovirus	NULL
promoter	NULL
)	NULL
increased	NULL
the	NULL
CAT	NULL
activity	NULL
by	NULL
6.5-fold	NULL
.	NULL

The	NULL
combined	NULL
induction	NULL
with	NULL
PMA	NULL
and	NULL
ICPO	NULL
resulted	NULL
in	NULL
an	NULL
11-fold	NULL
increase	NULL
of	NULL
the	NULL
CAT	NULL
activity	NULL
.	NULL

The	NULL
synergism	NULL
between	NULL
ICPO	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
proteins	NULL
was	NULL
even	NULL
more	NULL
apparent	NULL
when	NULL
the	NULL
HIV-1	NULL
LTR	NULL
CAT	NULL
plasmid	NULL
was	NULL
used	NULL
.	NULL

While	NULL
both	NULL
PMA	NULL
and	NULL
ICPO	NULL
stimulate	NULL
the	NULL
CAT	NULL
activity	NULL
about	NULL
3-	NULL
to	NULL
4-fold	NULL
,	NULL
combination	NULL
of	NULL
the	NULL
two	NULL
results	NULL
in	NULL
14-fold	NULL
induction	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

The	NULL
cotransfection	NULL
of	NULL
ICPO	NULL
with	NULL
plasmid	NULL
pBLCAT2	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
minimal	NULL
tk	NULL
promoter	NULL
and	NULL
which	NULL
is	NULL
expressed	NULL
only	NULL
at	NULL
very	NULL
low	NULL
levels	NULL
in	NULL
HSV-l-infected	NULL
cells	NULL
,	NULL
enhanced	NULL
the	NULL
levels	NULL
of	NULL
CAT	NULL
activity	NULL
only	NULL
2-fold	NULL
,	NULL
and	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
ICPO	NULL
increased	NULL
the	NULL
expression	NULL
about	NULL
4-fold	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
ICPO	NULL
,	NULL
which	NULL
is	NULL
a	NULL
rather	NULL
promiscuous	NULL
transcriptional	NULL
transactivator	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
reference	NULL
6	NULL
)	NULL
,	NULL
acts	NULL
in	NULL
cooperation	NULL
with	NULL
other	NULL
transcriptional	NULL
factors	NULL
bound	NULL
to	NULL
the	NULL
HIV-1	NULL
promoter	NULL
,	NULL
such	NULL
as	NULL
PMA-induced	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
proteins	NULL
.	NULL

When	NULL
similar	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
ICP4	NULL
expression	NULL
plasmid	NULL
,	NULL
no	NULL
significant	NULL
4430	NULL
NOTES	NULL
40	NULL
,	NULL
35	NULL
+	NULL
30	NULL
{	NULL
§	NULL
25	NULL
+	NULL
O	NULL
é	NULL
20	NULL
3	NULL
15	NULL
t	NULL
10	NULL
{	NULL
5	NULL
4	NULL
o	NULL
4	NULL
HIV-1	NULL
LTR	NULL
HIV-1	NULL
LTR/ACV	NULL
p23tkCAT	NULL
p23tkCAT/IACV	NULL
14	NULL
7	NULL
B	NULL
Ont	NULL
EPMA	NULL
12	NULL
{	NULL
GICPO	NULL
&	NULL
10	NULL
|	NULL
HPMA+ICPO	NULL
2	NULL
2	NULL
®	NULL
>	NULL
C	NULL
0	NULL
o	NULL
3e	NULL
pBLCAT2	NULL
p23tkCAT	NULL
HIV-1	NULL
LTR	NULL
@	NULL
t	NULL
c	NULL
Ont	NULL
RACV	NULL
50	NULL
+	NULL
®	NULL
HSV	NULL
H	NULL
HSV/ACV	NULL
%	NULL
conversion	NULL
8	NULL
[	NULL
3	NULL
$	NULL
10	NULL
+	NULL
ICPOCAT	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Effect	NULL
of	NULL
ACV	NULL
on	NULL
the	NULL
HSV-1-mediated	NULL
activation	NULL
of	NULL
the	NULL
p23tkCAT	NULL
and	NULL
the	NULL
HIV-1	NULL
LTR	NULL
CAT	NULL
plasmid	NULL
.	NULL

Cells	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
mg	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
,	NULL
and	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
they	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
for	NULL
16	NULL
h	NULL
)	NULL
or	NULL
infected	NULL
with	NULL
HSV-1	NULL
(	NULL
MOI	NULL
,	NULL
3	NULL
)	NULL
or	NULL
left	NULL
untreated	NULL
(	NULL
nt	NULL
.	NULL
)	NULL

.	NULL

The	NULL
same	NULL
experiment	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ACV	NULL
(	NULL
30	NULL
wM	NULL
)	NULL
,	NULL
which	NULL
was	NULL
added	NULL
to	NULL
all	NULL
samples	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

The	NULL
graph	NULL
shows	NULL
fold	NULL
induction	NULL
over	NULL
the	NULL
value	NULL
of	NULL
the	NULL
untreated	NULL
samples	NULL
.	NULL

The	NULL
basal	NULL
CAT	NULL
activities	NULL
of	NULL
the	NULL
uninduced	NULL
reporter	NULL
plasmids	NULL
(	NULL
using	NULL
50	NULL
ug	NULL
of	NULL
cell	NULL
lysates	NULL
at	NULL
37°C	NULL
for	NULL
2	NULL
h	NULL
)	NULL
,	NULL
expressed	NULL
in	NULL
counts	NULL
per	NULL
minute	NULL
of	NULL
acetylated	NULL
[	NULL
**C	NULL
)	NULL
chloramphenicol	NULL
,	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
HIV	NULL
LTR	NULL
CAT	NULL
,	NULL
3,100	NULL
;	NULL
HIV	NULL
LTR	NULL
CAT/ACV	NULL
,	NULL
3,500	NULL
;	NULL
p23tkCAT	NULL
,	NULL
1,020	NULL
;	NULL
and	NULL
p23TKCAT/ACV	NULL
,	NULL
960	NULL
.	NULL

The	NULL
results	NULL
represent	NULL
the	NULL
average	NULL
of	NULL
at	NULL
least	NULL
three	NULL
transfection	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Synergism	NULL
between	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
J.	NULL
Viror	NULL
.	NULL

increase	NULL
in	NULL
CAT	NULL
activity	NULL
was	NULL
observed	NULL
either	NULL
with	NULL
ICP4	NULL
alone	NULL
or	NULL
with	NULL
ICP4	NULL
in	NULL
combination	NULL
with	NULL
PMA	NULL
,	NULL
indicating	NULL
that	NULL
ICP4	NULL
alone	NULL
is	NULL
not	NULL
able	NULL
to	NULL
activate	NULL
the	NULL
p23tkCAT	NULL
or	NULL
the	NULL
HIV-1	NULL
LTR	NULL
CAT	NULL
plasmids	NULL
in	NULL
A3.01	NULL
cells	NULL
(	NULL
21	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
the	NULL
HIV-1	NULL
LTR	NULL
promoter	NULL
does	NULL
not	NULL
contain	NULL
the	NULL
ICP4	NULL
DNA	NULL
binding	NULL
motif	NULL
(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
cotransfection	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
ICPO	NULL
,	NULL
but	NULL
not	NULL
ICP4	NULL
,	NULL
can	NULL
transactivate	NULL
expression	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
promoter	NULL
region	NULL
(	NULL
11-13	NULL
)	NULL
,	NULL
and	NULL
we	NULL
have	NULL
shown	NULL
in	NULL
this	NULL
report	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
NF-xB	NULL
enhancer	NULL
region	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
LBP-1	NULL
region	NULL
is	NULL
sufficient	NULL
for	NULL
the	NULL
ICPO-mediated	NULL
transactivation	NULL
.	NULL

However	NULL
,	NULL
using	NULL
the	NULL
ICP4	NULL
deletion	NULL
mutant	NULL
of	NULL
HSV-1	NULL
,	NULL
Albrecht	NULL
et	NULL
al	NULL
.	NULL

(	NULL
2	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
function	NULL
of	NULL
ICP4	NULL
,	NULL
and	NULL
not	NULL
that	NULL
of	NULL
ICPO	NULL
,	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
augmentation	NULL
of	NULL
HIV-1	NULL
replication	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
reason	NULL
for	NULL
this	NULL
discrepancy	NULL
is	NULL
not	NULL
obvious	NULL
;	NULL
it	NULL
may	NULL
,	NULL
however	NULL
,	NULL
indicate	NULL
either	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
IE	NULL
genes	NULL
in	NULL
the	NULL
context	NULL
of	NULL
viral	NULL
infection	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
isolated	NULL
transfected	NULL
genes	NULL
are	NULL
not	NULL
identical	NULL
or	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
an	NULL
early	NULL
and	NULL
late	NULL
gene	NULL
(	NULL
s	NULL
)	NULL
,	NULL
which	NULL
is	NULL
blocked	NULL
in	NULL
the	NULL
ICP4-defective	NULL
HSV-1	NULL
mutant	NULL
,	NULL
is	NULL
required	NULL
for	NULL
the	NULL
HIV-1	NULL
induction	NULL
.	NULL

In	NULL
the	NULL
course	NULL
of	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
tested	NULL
two	NULL
HSV-1	NULL
mutants	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
activate	NULL
HIV-1	NULL
replication	NULL
in	NULL
ACH-2	NULL
cells	NULL
.	NULL

The	NULL
first	NULL
was	NULL
the	NULL
VP16	NULL
mutant	NULL
,	NULL
in1814	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
virion	NULL
protein	NULL
VP16	NULL
is	NULL
one	NULL
of	NULL
the	NULL
most	NULL
efficient	NULL
transactivators	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
determine	NULL
whether	NULL
this	NULL
gene	NULL
also	NULL
participates	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

However	NULL
,	NULL
the	NULL
VP16	NULL
mutant	NULL
was	NULL
able	NULL
to	NULL
induce	NULL
HIV-1	NULL
expression	NULL
nearly	NULL
as	NULL
efficiently	NULL
as	NULL
the	NULL
parental	NULL
HSV-1	NULL
(	NULL
21	NULL
)	NULL
.	NULL

These	NULL
results	NULL
,	NULL
together	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
VP16	NULL
overexpression	NULL
did	NULL
not	NULL
activate	NULL
HIV-1	NULL
LTR	NULL
in	NULL
a	NULL
transient-transfection	NULL
assay	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
exclude	NULL
the	NULL
participation	NULL
of	NULL
VP16	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
provirus	NULL
.	NULL

The	NULL
second	NULL
mutated	NULL
virus	NULL
tested	NULL
was	NULL
the	NULL
protein	NULL
kinase	NULL
mutant	NULL
of	NULL
HSV-1	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
is	NULL
at	NULL
least	NULL
partially	NULL
a	NULL
consequence	NULL
of	NULL
phosphorylation	NULL
of	NULL
IxB	NULL
(	NULL
8	NULL
)	NULL
,	NULL
it	NULL
was	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
virus-encoded	NULL
kinase	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
and	NULL
the	NULL
HIV-1	NULL
induction	NULL
process	NULL
.	NULL

However	NULL
,	NULL
both	NULL
the	NULL
kinase	NULL
mutants	NULL
and	NULL
the	NULL
parental	NULL
virus	NULL
were	NULL
able	NULL
to	NULL
induce	NULL
expression	NULL
of	NULL
the	NULL
HIV-1	NULL
provirus	NULL
and	NULL
NF-kB	NULL
binding	NULL
proteins	NULL
to	NULL
a	NULL
similar	NULL
extent	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
this	NULL
study	NULL
show	NULL
that	NULL
,	NULL
while	NULL
the	NULL
inhibition	NULL
of	NULL
expression	NULL
of	NULL
late	NULL
genes	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
HSV-1-mediated	NULL
induction	NULL
of	NULL
HIV-1	NULL
provirus	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
HLP-1	NULL
proteins	NULL
are	NULL
significantly	NULL
reduced	NULL
when	NULL
the	NULL
later	NULL
stages	NULL
of	NULL
HSV-1	NULL
infection	NULL
and	NULL
virus	NULL
production	NULL
are	NULL
inhibited	NULL
.	NULL

We	NULL
believe	NULL
that	NULL
these	NULL
results	NULL
are	NULL
not	NULL
an	NULL
indication	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
HLP-1	NULL
proteins	NULL
do	NULL
not	NULL
play	NULL
any	NULL
role	NULL
in	NULL
the	NULL
HSV-1-mediated	NULL
activation	NULL
of	NULL
HIV-1	NULL
provirus	NULL
but	NULL
rather	NULL
and	NULL
ICPO	NULL
.	NULL

A3.01	NULL
cells	NULL
(	NULL
1	NULL
x	NULL
10	NULL
``	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
and	NULL
6	NULL
pg	NULL
of	NULL
either	NULL
the	NULL
nonspecific	NULL
DNA	NULL
or	NULL
pGH94	NULL
(	NULL
ICPO	NULL
gene	NULL
under	NULL
control	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
promoter	NULL
)	NULL
.	NULL

Where	NULL
stated	NULL
,	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
.	NULL

Values	NULL
on	NULL
the	NULL
y	NULL
axis	NULL
show	NULL
the	NULL
percent	NULL
conversion	NULL
of	NULL
the	NULL
[	NULL
'*C	NULL
]	NULL
chloramphenicol	NULL
to	NULL
the	NULL
acetylated	NULL
form	NULL
with	NULL
50	NULL
pg	NULL
of	NULL
cell	NULL
lysate	NULL
at	NULL
37°C	NULL
for	NULL
2	NULL
h.	NULL
(	NULL
C	NULL
)	NULL
ACV	NULL
treatment	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
ICPO	NULL
promoter	NULL
in	NULL
HSV-l-infected	NULL
cells	NULL
.	NULL

A3.01	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10	NULL
``	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
12	NULL
mg	NULL
of	NULL
the	NULL
ICPO-CAT	NULL
reporter	NULL
plasmid	NULL
,	NULL
and	NULL
after	NULL
24	NULL
h	NULL
(	NULL
18	NULL
)	NULL
cells	NULL
were	NULL
split	NULL
into	NULL
four	NULL
portions	NULL
;	NULL
the	NULL
first	NULL
was	NULL
left	NULL
untreated	NULL
(	NULL
n.t	NULL
.	NULL
)	NULL

,	NULL
the	NULL
second	NULL
was	NULL
treated	NULL
with	NULL
30	NULL
uM	NULL
ACV	NULL
,	NULL
the	NULL
third	NULL
was	NULL
infected	NULL
with	NULL
HSV-1	NULL
(	NULL
3	NULL
MOI	NULL
)	NULL
,	NULL
and	NULL
the	NULL
fourth	NULL
was	NULL
infected	NULL
with	NULL
HSV-1	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
30	NULL
uM	NULL
ACV	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
measured	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
the	NULL
cell	NULL
lysate	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Values	NULL
represent	NULL
averages	NULL
of	NULL
three	NULL
transfections	NULL
.	NULL

Vor	NULL
.	NULL

67	NULL
,	NULL
1993	NULL
support	NULL
our	NULL
previous	NULL
observation	NULL
that	NULL
even	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
can	NULL
efficiently	NULL
activate	NULL
the	NULL
expression	NULL
of	NULL
HIV-1	NULL
provirus	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
HIV-1	NULL
provirus	NULL
by	NULL
HSV-1	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
combined	NULL
effect	NULL
of	NULL
several	NULL
transactivators	NULL
,	NULL
such	NULL
as	NULL
NF-kB	NULL
,	NULL
HLP-1	NULL
,	NULL
and	NULL
ICPO	NULL
proteins	NULL
.	NULL

The	NULL
complementation	NULL
and	NULL
cooperation	NULL
between	NULL
the	NULL
cellular	NULL
transactivators	NULL
such	NULL
as	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
proteins	NULL
and	NULL
the	NULL
virus-encoded	NULL
IE	NULL
gene	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
ICPO	NULL
,	NULL
allow	NULL
effective	NULL
HIV-1	NULL
transactivation	NULL
even	NULL
under	NULL
conditions	NULL
in	NULL
which	NULL
the	NULL
HSV-1	NULL
replication	NULL
is	NULL
impaired	NULL
and	NULL
the	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
HLP-1	NULL
transactivators	NULL
are	NULL
significantly	NULL
reduced	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
ACV-mediated	NULL
inhibition	NULL
of	NULL
HSV-1	NULL
replication	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
stimulation	NULL
of	NULL
HIV-1	NULL
provirus	NULL
expression	NULL
but	NULL
,	NULL
in	NULL
contrast	NULL
,	NULL
enhances	NULL
the	NULL
production	NULL
of	NULL
HIV-1	NULL
virions	NULL
is	NULL
of	NULL
particular	NULL
interest	NULL
,	NULL
since	NULL
a	NULL
number	NULL
of	NULL
clinical	NULL
protocols	NULL
used	NULL
in	NULL
AIDS	NULL
therapy	NULL
combine	NULL
ACV	NULL
and	NULL
antiretrovirus	NULL
treatment	NULL
.	NULL

We	NULL
thank	NULL
Charles	NULL
Preston	NULL
for	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
the	NULL
VP16	NULL
defective	NULL
mutant	NULL
,	NULL
Gary	NULL
Hayward	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
ICPO-CAT	NULL
and	NULL
pGH94	NULL
plasmids	NULL
,	NULL
and	NULL
Bernard	NULL
Roizman	NULL
for	NULL
helpful	NULL
suggestions	NULL
and	NULL
for	NULL
the	NULL
protein	NULL
kinase-defective	NULL
mutant	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Barbara	NULL
Schneider	NULL
for	NULL
typing	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
grants	NULL
AI26123	NULL
and	NULL
A1I27297	NULL
)	NULL
and	NULL
the	NULL
American	NULL
Foundation	NULL
for	NULL
AIDS	NULL
Research	NULL
(	NULL
grants	NULL
001502	NULL
and	NULL
001684	NULL
)	NULL
to	NULL
P.M.P	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Ace	NULL
,	NULL
C.	NULL
I.	NULL
,	NULL
T.	NULL
A.	NULL
McKee	NULL
,	NULL
J.	NULL
M.	NULL
Ryan	NULL
,	NULL
J.	NULL
M.	NULL
Cameron	NULL
,	NULL
and	NULL
C.	NULL
M.	NULL
Preston	NULL
.	NULL

1989	NULL
.	NULL

Construction	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
1	NULL
mutant	NULL
unable	NULL
to	NULL
transinduce	NULL
immediate-early	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:2260-2269	NULL
.	NULL

2	NULL
.	NULL

Albrecht	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
N.	NULL
A.	NULL
DeLuca	NULL
,	NULL
R.	NULL
A.	NULL
Byrn	NULL
,	NULL
P.	NULL
A.	NULL
Schaffer	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Hammer	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
herpes	NULL
simplex	NULL
virus	NULL
immediate-early	NULL
protein	NULL
,	NULL
ICP4	NULL
,	NULL
is	NULL
required	NULL
to	NULL
potentiate	NULL
replication	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
CD4+	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63	NULL
:	NULL
1861-1868	NULL
.	NULL

3	NULL
.	NULL

Chomczynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
N.	NULL
Sacchi	NULL
.	NULL

1987	NULL
.	NULL

Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloro-form	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162:156-159	NULL
.	NULL

4	NULL
.	NULL

Clouse	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
D.	NULL
Powell	NULL
,	NULL
I.	NULL
Washington	NULL
,	NULL
G.	NULL
Poli	NULL
,	NULL
K.	NULL
Strebel	NULL
,	NULL
W.	NULL
Farrar	NULL
,	NULL
P.	NULL
Barstad	NULL
,	NULL
J.	NULL
Kovacs	NULL
,	NULL
A.	NULL
S.	NULL
Fauci	NULL
,	NULL
and	NULL
T.	NULL
M.	NULL
Folks	NULL
.	NULL

1989	NULL
.	NULL

Monokine	NULL
regulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus-1	NULL
expression	NULL
in	NULL
a	NULL
chronically	NULL
infected	NULL
human	NULL
T-cell	NULL
line	NULL
.	NULL

J.	NULL
Immu-nol	NULL
.	NULL

142:431-438	NULL
.	NULL

5	NULL
.	NULL

Cullen	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Green	NULL
.	NULL

1989	NULL
.	NULL

Regulatory	NULL
pathways	NULL
governing	NULL
HIV-1	NULL
replication	NULL
.	NULL

Cell	NULL
58:423-426	NULL
.	NULL

6	NULL
.	NULL

Everett	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
C.	NULL
M.	NULL
Preston	NULL
,	NULL
and	NULL
N.	NULL
D.	NULL
Stow	NULL
.	NULL

1991	NULL
.	NULL

Functional	NULL
and	NULL
genetic	NULL
analysis	NULL
of	NULL
the	NULL
role	NULL
of	NULL
Vmw110	NULL
in	NULL
herpes	NULL
simplex	NULL
virus	NULL
replication	NULL
,	NULL
p.	NULL
49-76	NULL
.	NULL

In	NULL
E.	NULL
K.	NULL
Wager	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Herpesvirus	NULL
transcription	NULL
and	NULL
its	NULL
regulation	NULL
.	NULL

CRC	NULL
Press	NULL
,	NULL
Boca	NULL
Raton	NULL
,	NULL
Fla.	NULL
7	NULL
.	NULL

Farber	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
and	NULL
K.	NULL
W.	NULL
Wilcox	NULL
.	NULL

1986	NULL
.	NULL

Association	NULL
of	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
regulatory	NULL
protein	NULL
ICP4	NULL
with	NULL
specific	NULL
nucleotide	NULL
sequences	NULL
in	NULL
DNA	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

14:6067-6083	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21.	NULL
.	NULL

Weber	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
J.	NULL
J.	NULL
Kenny	NULL
,	NULL
and	NULL
B.	NULL
Wigdahl	NULL
.	NULL

1992	NULL
.	NULL

Antiviral	NULL
NOTES	NULL
4431	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
in	NULL
vitro	NULL
of	NULL
NF-kB	NULL
by	NULL
phosphorylation	NULL
of	NULL
its	NULL
inhibitor	NULL
IxB	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344	NULL
:	NULL
678-682.	NULL
.	NULL

Margolis	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
J.	NULL
M.	NULL
Ostrove	NULL
,	NULL
and	NULL
S.	NULL
E.	NULL
Straus	NULL
.	NULL

1993	NULL
.	NULL

HSV-1	NULL
activation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
is	NULL
augmented	NULL
by	NULL
a	NULL
cellular	NULL
protein	NULL
that	NULL
binds	NULL
near	NULL
the	NULL
initiator	NULL
element	NULL
.	NULL

Virology	NULL
192:370-374	NULL
.	NULL

Margolis	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
,	NULL
S.	NULL
E.	NULL
Straus	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Ostrove	NULL
.	NULL

1992	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
by	NULL
HSV-1	NULL
immediate-early	NULL
genes	NULL
.	NULL

Virology	NULL
186:788-791	NULL
.	NULL

Mosca	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
D.	NULL
P.	NULL
Bednarik	NULL
,	NULL
N.	NULL
B.	NULL
K.	NULL
Raj	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
W.	NULL
A.	NULL
Haseltine	NULL
,	NULL
G.	NULL
S.	NULL
Hayward	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Pitha	NULL
.	NULL

1987	NULL
.	NULL

Activation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
by	NULL
herpesvirus	NULL
infection	NULL
:	NULL
identification	NULL
of	NULL
a	NULL
region	NULL
within	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
that	NULL
responds	NULL
to	NULL
a	NULL
trans-acting	NULL
factor	NULL
encoded	NULL
by	NULL
herpes	NULL
simplex	NULL
virus	NULL
1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:7408-7412	NULL
.	NULL

Mosca	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
D.	NULL
P.	NULL
Bednarik	NULL
,	NULL
N.	NULL
B.	NULL
K.	NULL
Raj	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
W.	NULL
A.	NULL
Haseltine	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Pitha	NULL
.	NULL

1987	NULL
.	NULL

Herpes	NULL
simplex	NULL
virus	NULL
type-1	NULL
can	NULL
reactivate	NULL
transcription	NULL
of	NULL
latent	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
325:67-70	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

Rice	NULL
,	NULL
D.	NULL
M.	NULL
Knipe	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Alternative	NULL
mechanisms	NULL
for	NULL
activation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Science	NULL
239:1299-1302	NULL
.	NULL

Ostrove	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
J.	NULL
Leonard	NULL
,	NULL
K.	NULL
E.	NULL
Weck	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
,	NULL
and	NULL
H.	NULL
E.	NULL
Gendelman	NULL
.	NULL

1987	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
by	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61:3726-3732	NULL
.	NULL

Pavlakis	NULL
,	NULL
G.	NULL
N.	NULL
,	NULL
and	NULL
B.	NULL
K.	NULL
Felber	NULL
.	NULL

1991	NULL
.	NULL

Regulation	NULL
of	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

2:20-31	NULL
.	NULL

Pitha	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
and	NULL
D.	NULL
P.	NULL
Bednarik	NULL
.	NULL

1990.	NULL
frans-activation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
promoter	NULL
by	NULL
heterologous	NULL
virus	NULL
infection	NULL
,	NULL
p.	NULL
289-308	NULL
.	NULL

In	NULL
L.	NULL
Aurelian	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Developments	NULL
in	NULL
medical	NULL
virology	NULL
.	NULL

6	NULL
.	NULL

Herpesviruses	NULL
,	NULL
the	NULL
immune	NULL
sys-tem	NULL
,	NULL
and	NULL
AIDS	NULL
.	NULL

Kluwer	NULL
Academic	NULL
Publishers	NULL
,	NULL
Boston	NULL
.	NULL

Purves	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
R.	NULL
M.	NULL
Longnecker	NULL
,	NULL
D.	NULL
P.	NULL
Leader	NULL
,	NULL
and	NULL
B.	NULL
Roizman	NULL
.	NULL

1987	NULL
.	NULL

Herpes	NULL
simplex	NULL
virus	NULL
1	NULL
protein	NULL
kinase	NULL
is	NULL
encoded	NULL
by	NULL
open	NULL
reading	NULL
frame	NULL
US3	NULL
which	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
virus	NULL
growth	NULL
in	NULL
cell	NULL
culture	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61:2896-2901	NULL
.	NULL

Roberts	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
A.	NULL
Boundy	NULL
,	NULL
P.	NULL
O'Hare	NULL
,	NULL
M.	NULL
C.	NULL
Pizzorno	NULL
,	NULL
D.	NULL
M.	NULL
Ciufo	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

1988	NULL
.	NULL

Direct	NULL
correlation	NULL
between	NULL
a	NULL
negative	NULL
autoregulatory	NULL
response	NULL
element	NULL
at	NULL
the	NULL
cap	NULL
site	NULL
of	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
1	NULL
IE175	NULL
(	NULL
a4	NULL
)	NULL
promoter	NULL
and	NULL
a	NULL
specific	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
IE175	NULL
(	NULL
ICP4	NULL
)	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

62:4307-4320	NULL
.	NULL

Vlach	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Pitha	NULL
.	NULL

1992	NULL
.	NULL

Activation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
provirus	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
macrophages	NULL
is	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
inducer-specific	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
proteins	NULL
.	NULL

Virology	NULL
187:63-72	NULL
.	NULL

Vlach	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Pitha	NULL
.	NULL

1992	NULL
.	NULL

Herpes	NULL
simplex	NULL
virus	NULL
type	NULL
1-mediated	NULL
induction	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
provirus	NULL
correlates	NULL
with	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
enhancer	NULL
and	NULL
leader	NULL
sequence	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:3616-3623	NULL
.	NULL

Vlach	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Pitha	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

properties	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
mutant	NULL
of	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
1	NULL
regulatory	NULL
protein	NULL
ICPO	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

73:2955-2961	NULL
.	NULL

